Vision Research Report, Recently Announced New Report on “medical foods market – Global Industry Analysis, Market Size, Share, Growth, Trends, Region Outlook, And Segment Forecasts, 2021 – 2030″.
Global “Medical foods market” Report 2021 covering manufacturers, regions, segments, forecast to 2030 is that the recent research report with correct information and extremely authentic info. The report provides insights on market share, market size, rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors. The Medical foods research report focuses on the competitive surroundings that has section on company profile covering product specifications, geographical coverage, recent developments, revenue analysis, and market shares. what is more, the report offers strategic recommendations so as to help the consumers to align business goals.
The Medical foods market revenue share is set to grow at a yearly rate of 5.1% during 2021-2030, while its valuation is Projected to jump from $ 20.2 Bn in 2020 to $32.5 Bn in 2030.
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39141
By Product Analysis
The powder segment accounted for the largest revenue share of over 35.0% in 2021 owing to the high commercial availability of medical foods in the form of powder. In addition, increasing preference and ease in consumption by the pediatric and geriatric patients suffering from different chronic diseases are fueling the segment growth.
The liquid segment is anticipated to grow at the fastest rate during the forecast period owing to the rising adoption of liquid formulations in the pediatric and geriatric population, where the intake of solid formulations is limited or impossible and in case of clinically diagnosed dysphagia or when oral physiology is limited.
By Application Analysis
Chemotherapy-induced diarrhea accounted for the largest revenue share of over 15.0% in 2021. Diarrheal episodes interfere with the chemotherapy process and dosage pattern. Therefore, the rising need for adopting medical foods in dietary management is expected to boost the segment growth.
Because of loss of absorptive surfaces and potential mucosal damage due to chemotherapy-related diarrhea, patients should ingest specific easy-to-digest medical food, which is expected to fuel the segment growth over the forecast years.
Diabetic neuropathy is anticipated to be the fastest-growing segment over the forecast period owing to the growing prevalence of diabetes and a rise in the number of patients that are at risk of developing some level of neuropathy.
The growing number of patients suffering from diabetic neuropathy and increasing prescription by medical professionals for medical food consumption to manage the disease are the major factors propelling the segment growth. The growing prevalence of diabetic neuropathy all over the globe is further supporting the growth of the segment.
By Sales Channel Analysis
The institutional sales channel, which includes hospitals, home care settings, and disability facilities, accounted for the largest revenue share of over 40.0% in 2021. The growing number of patient visits to the hospitals and other healthcare facilities for the diagnosis and treatment of several chronic and dietary disorders is driving the segment.
The increasing preference among the patients to consult a doctor in the hospitals for their chronic disease management will drive the segment. Moreover, the growing number of private and public healthcare institutions and the increasing chronic disease patient population across the globe will support the segment growth.
The online sales segment is anticipated to expand at the fastest rate over the forecast period. Preference for the online purchase of medical foods is rising owing to the convenience offered by this sales channel. Although medical foods are mainly consumed under medical surveillance, these are intended for long-term nutrition management, which is resulting in surging sales through e-commerce.
By Regional Analysis
North America held the largest revenue share of over 30.0%. The presence of international companies such as Abbott Laboratories and Mead Johnson & Company and the high revenue generation of these companies are driving the market.
The Asia Pacific region is anticipated to be the fastest-growing regional market over the forecast period owing to the increasing rate of cancer and diabetic patients, along with several government initiatives in the healthcare segment.
Johnson & Johnson Pte. Ltd. company, Asia Pacific hosts about 50% of new cancer cases in the world each year. Further, this report stated that the death due to cancer is estimated to increase by 36% in the Asia Pacific region by 203o, which, in turn, is expected to propel the growth of the market in this region over the coming years.
Global Medical foods market report provides key statistics on the state of the trade and could be a valuable supply of steerage and direction for corporations and people curious about the market. The Medical foods trade trends and promoting channels analysed. Medical foods Market discovers numerous topics like regional market scope, product market numerous applications, market size consistent with specific product, sales and revenue by region, producing analysis, Industrial Chain, Market result Factors Analysis, market size forecast, and more. Finally, the practicableness of latest investment comes is evaluated and overall analysis conclusions offered.
Key Players
Market Segmentation
Global Medical foods Market: Drivers and Restrains
The analysis report has incorporated the analysis of various factors that augment the market’s growth. It constitutes trends, restraints, and drivers that remodel the market in either a positive or negative manner. This section additionally provides the scope of various segments and applications that may probably influence the market within the future. The elaborated info is predicated on current trends and historic milestones. This section additionally provides an analysis of the amount of production regarding the world market and regarding every kind from 2021-2030.
COVID-19 impact on the Medical foods market
COVID-19 is associate communicable disease caused by the novel coronavirus. for the most part unknown before this happening across the world, COVID-19 has captive from a regional crisis to a worldwide pandemic in precisely a matter of a number of weeks. the world Health Organization (WHO) declared COVID-19 as an epidemic on March 11, 2021.
COVID-19 has compact most the industries across the world by disrupting provide chains and impeding numerous industrial operations. COVID-19-responsive measures undertaken by governments, like lockdown and social distancing, led to the closure of producing plants in the initial stage of the pandemic. With only a few industrial operations allowed, the demand for numerous input product within the industrial sector has declined considerably.
Key Highlights Involved in the Market Research Report: –
Medical foods Market Study Coverage: It includes key market segments, key makers covered, the scope of product offered within the years thought of, world Medical foods Market and study objectives. in addition, it touches the segmentation study provided within the report on the idea of the sort of product and applications.
Medical foods Market executive Summary: This section emphasizes the key studies, market rate, competitive landscape, market drivers, trends, and problems additionally to the gross indicators.
Medical foods Market Production by Region: The report delivers knowledge associated with import and export, revenue, production, and key players of all regional markets studied area unit coated during this section.
Medical foods Market Profile of Manufacturers: Analysis of every market player profiled is elaborated during this section. This section conjointly provides SWOT analysis, products, production, value, capacity, and different very important factors of the individual player.
The report delivers a comprehensive study of all the segments and shares info concerning the leading regions within the market. This report additionally states import/export consumption, offer and demand Figures, cost, business share, policy, price, revenue, and gross margins.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Application Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Medical Foods Market, By Route of Administration
7.1. Medical Foods Market, by Route of Administration, 2021-2030
7.1.1. Oral
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Enteral
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Medical Foods Market, By Product
8.1. Medical Foods Market, by Product, 2021-2030
8.1.1. Pills
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Powder
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Liquid
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Medical Foods Market, By Application
9.1. Medical Foods Market, by Application, 2021-2030
9.1.1. Chronic Kidney Disease
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Minimal Hepatic Encephalopathy
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Chemotherapy Induced Diarrhea
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Pathogen Related Infections
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Diabetic Neuropathy
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. ADHD
9.1.6.1. Market Revenue and Forecast (2019-2030)
9.1.7. Depression
9.1.7.1. Market Revenue and Forecast (2019-2030)
9.1.8. Alzheimer’s Disease
9.1.8.1. Market Revenue and Forecast (2019-2030)
9.1.9. Nutritional Deficiency
9.1.9.1. Market Revenue and Forecast (2019-2030)
9.1.10. Orphan diseases
9.1.10.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Medical Foods Market, By Sales Channel
10.1. Medical Foods Market, by Sales Channel, 2021-2030
10.1.1. Online Sales
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Institutional Sales
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Retail Sales
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Medical Foods Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.1.2. Market Revenue and Forecast, by Product (2019-2030)
11.1.3. Market Revenue and Forecast, by Application (2019-2030)
11.1.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.1.6.2. Market Revenue and Forecast, by Product (2019-2030)
11.1.6.3. Market Revenue and Forecast, by Application (2019-2030)
11.1.6.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.2.2. Market Revenue and Forecast, by Product (2019-2030)
11.2.3. Market Revenue and Forecast, by Application (2019-2030)
11.2.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.3. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.3. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.2.8.2. Market Revenue and Forecast, by Product (2019-2030)
11.2.8.3. Market Revenue and Forecast, by Application (2019-2030)
11.2.8.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.3.2. Market Revenue and Forecast, by Product (2019-2030)
11.3.3. Market Revenue and Forecast, by Application (2019-2030)
11.3.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.3. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.3. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.3.8.2. Market Revenue and Forecast, by Product (2019-2030)
11.3.8.3. Market Revenue and Forecast, by Application (2019-2030)
11.3.8.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.4.2. Market Revenue and Forecast, by Product (2019-2030)
11.4.3. Market Revenue and Forecast, by Application (2019-2030)
11.4.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.3. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.3. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.4.8.2. Market Revenue and Forecast, by Product (2019-2030)
11.4.8.3. Market Revenue and Forecast, by Application (2019-2030)
11.4.8.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.5.2. Market Revenue and Forecast, by Product (2019-2030)
11.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.5.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.5.6.2. Market Revenue and Forecast, by Product (2019-2030)
11.5.6.3. Market Revenue and Forecast, by Application (2019-2030)
11.5.6.4. Market Revenue and Forecast, by Sales Channel (2019-2030)
Chapter 12. Company Profiles
12.1. Nestle
12.1.1. Company Overview
12.1.2. Route of Administration Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Danone
12.2.1. Company Overview
12.2.2. Route of Administration Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Abbott
12.3.1. Company Overview
12.3.2. Route of Administration Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Mead Johnson & Company, LLC
12.4.1. Company Overview
12.4.2. Route of Administration Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Fresenius Kabi
12.5.1. Company Overview
12.5.2. Route of Administration Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Targeted Medical Pharma, Inc.
12.6.1. Company Overview
12.6.2. Route of Administration Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Primus Pharmaceuticals, Inc.
12.7.1. Company Overview
12.7.2. Route of Administration Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Medtrition, Inc.
12.8.1. Company Overview
12.8.2. Route of Administration Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39141
About Us: Vision Research Reports is unquestionably an expert in providing research reports on a diverse number of subjects including Alternative and Green Energy, Chemical, Energy, Glass, Machinery, Manufacturing, and Pharmaceuticals and Materials. We cater to distinguished MNCs, private equity firms, SMEs and Chinese companies pertaining to their market research data requirements.
We offer generic and amalgamated studies as well as customized studies to our clients based on their specific requirements. Our modus operandi constitutes of detailed and meticulous market surveys, company profiling, competitive landscaping and primary interviews. Our prudent insights have been vital in the inception of many investment programs, new project development programs, startups and technology breakthroughs.
Contact Us:
Call: +1 9197 992 333
Vision Research Reports
Any Assistance, Email – sales@visionresearchreports.com
Vision Research Report, Recently Announced New Report on "Smart Lock market - Global Industry Analysis,…
Vision Research Report, Recently Announced New Report on "2D barcode reader market - Global Industry…
Vision Research Report, Recently Announced New Report on "commercial refrigeration equipment market - Global Industry…
Vision Research Report, Recently Announced New Report on "Restaurant Point-of-Sale Terminal market - Global Industry…
Vision Research Report, Recently Announced New Report on "vacuum cleaner market- Global Industry Analysis, Market…
Vision Research Report, Recently Announced New Report on "household refrigerators and freezers market - Global…